Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

K0MR vs GERD


K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF
IE000FPWSL69 · Equity · Global · Multifattoriale
GERDL&G Gerd Kommer Multifactor Equity UCITS ETF
IE0001UQQ933 · Equity · Global · Multifattoriale
Open the interactive comparison on rebalix.com →

Comparison window: 15 Jun 202331 Jul 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 10 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixK0MR vs GERD · report of 10 September 2026

The funds at a glance

From official issuer documents and the ESMA register
K0MRIE000FPWSL69L&G Gerd Kommer Multifactor Equity UCITS ETFEquity · Global · Multifattoriale
Declared index
Solactive Gerd Kommer Multifactor Equity Index NTR
TER
0.45%
Transaction (KID)
0.08%
Fund size
1.5 mld EUR
Launch
21 Jun 2023
Currency
USD
Replication
Physical (sampled)
Hedging
No
Holdings
0
Distributions 12m
0.22 USD
Effective 🇮🇹 rate
GERDIE0001UQQ933L&G Gerd Kommer Multifactor Equity UCITS ETFEquity · Global · Multifattoriale
Declared index
Solactive Gerd Kommer Multifactor Equity Index NTR
TER
0.45%
Transaction (KID)
0.08%
Fund size
1.5 mld EUR
Launch
21 Jun 2023
Currency
USD
Replication
Physical (sampled)
Hedging
No
Holdings
0
Distributions 12m
acc.
Effective 🇮🇹 rate

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
K0MRn/d
2025
−0.28%
2024
−0.49%
GERDn/d
2025
−0.28%
2024
−0.49%
Rebalix · K0MR vs GERDsection 1 of 3
RebalixK0MR vs GERD · report of 10 September 2026
K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF · IE000FPWSL69 · Equity · Global · Multifattoriale
GERDL&G Gerd Kommer Multifactor Equity UCITS ETF · IE0001UQQ933 · Equity · Global · Multifattoriale

Performance over the period, in euro

From 15 Jun 2023 to 31 Jul 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10016195157157
In today’s purchasing power (net of Italy inflation)
10016195150150
K0MRGERD
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-5%-10%-15%-20%K0MRGERD202420252026trough K0MR: −18.4% · 07 Apr 2025trough GERD: −18.2% · 07 Apr 2025
Filled area: K0MR; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
K0MR−18.4%07 Apr 2025182 days230 days · back to break-even on 06 Oct 2025
GERD−18.2%07 Apr 2025177 days225 days · back to break-even on 01 Oct 2025
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-5%-10%-15%-20%K0MRGERD202420252026trough K0MR: −20.0% · 07 Apr 2025trough GERD: −19.8% · 07 Apr 2025
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · K0MR vs GERDsection 2 of 3
RebalixK0MR vs GERD · report of 10 September 2026

Full comparison table

"—" = not published by the source, never estimated
K0MRL&G Gerd Kommer Multifactor Equity UCITS ETF · IE000FPWSL69 · Equity · Global · Multifattoriale
GERDL&G Gerd Kommer Multifactor Equity UCITS ETF · IE0001UQQ933 · Equity · Global · Multifattoriale
MetricK0MRGERDNote
Identity
CategoryEquity · Global · MultifattorialeEquity · Global · MultifattorialeRebalix engine classification
ReplicationPhysical (sampled)Physical (sampled)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policydistributingaccumulating
Costs
TER0.45%0.45%from the KID
Transaction costs (KID)0.08%0.08%internal
All-in cost0.53%0.53%TER + transaction
Tracking difference (3a)vs its OWN index
Performance in euro (ECB rates)
1 year+22.3%+22.3%
3 years+54.1%+54.1%
5 years
10 years— = series younger than the window
Risk · last 3 years
Volatility (ann.)+11.47%+11.48%
Max drawdown−14.35%−14.17%
Sharpe1.201.34risk-free = ECB MRO avg
Sortino1.701.91like Sharpe, downside only
Distributions (fund currency)
Frequencyquarterlyaccumulating class
Distributions, last 12 months0.22 USDaccumulating classper share
Distribution yield1.32%accumulating class12 months / NAV
Last ex-date11 Jun 2026 · 0.0997 USDaccumulating class
Italian taxation
Effective capital-gains ratewhite list, current half-year
Documents & exchanges
Listing venues89ESMA register
Borsa Italiana tickerGERD
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~335 euro K0MR · ~335 euro GERD. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · K0MR vs GERDsection 3 of 3